CD8A and COVID-19: Here, we investigated the dynamic changes of CD3−CD19+B cells, T cell subsets (CD3+CD4+ T cells, CD3+CD8+ T cells, DN T cells and Tregs), and CD3−CD16+CD56+ natural killer (NK) cells during both the acute infective and convalescent periods in patients with mild, severe, and critical COVID-19.